Babson Diagnostics welcomes Mini Kahlon to its Board of Directors

May 14, 2019

Austin, Texas, May 14, 2019 — Babson Diagnostics, Inc., a healthcare technology company focused on moving laboratory testing to the pharmacy counter, welcomed Mini Kahlon as the newest member of its Board of Directors. Regarding her commitment to Babson’s success, Mini expressed, “I believe the space Babson is moving into has significant potential to move the cost and experience curves, and is essential to the vision of delivering healthcare where we live, work, eat, and play.”

Maninder “Mini” Kahlon is Vice Dean for the Health Ecosystem at the UT Dell Medical School, which she helped to launch. Preceding this role, Mini served as Chief Information Officer and Executive Director for UCSF’s Clinical and Translational Science Institute. Focused on advancing healthcare innovation, Dr. Kahlon has served as Vice Chair of MedTech Innovation for the Austin Chamber of Commerce Board of Directors, Founding Co-Chair of the Austin Healthcare Council, and, as of 2019, Executive Director of Factor Health, a program that builds new businesses to address the broader social and behavioral drivers of health. Dr. Kahlon graduated from Bryn Mawr College and earned a Ph.D. in Neuroscience from the University of California, San Francisco.

About Babson Diagnostics

Babson Diagnostics is a healthcare technology company focused on moving laboratory testing to the pharmacy counter. Babson has developed a model for diagnostic blood testing that maintains a high standard of accuracy, yet requires only one-tenth the sample size of traditional venipuncture methods.

Keep up with our latest news